Adam Khoo

@AdamKhoo

Return

+1.9%

Hit rate

46%

Open calls

Closed

Open calls

Ticker	Called	Entry	Now	Return
AMZN	Jan 13, 2026	$242.60	$231.39	-4.6%
Largest portfolio position; underperformed in 2025 but believes it will be the next Alphabet and one of the best performers in the next couple of years.
NVDA	Jan 13, 2026	$185.81	$196.51	+5.8%
Core holding; still projected to grow 31.96% over 3-5 years and 26.26% beyond. Slightly undervalued at $184 vs $215 intrinsic.
BABA	Feb 20, 2025	$135.97	$115.00	-15.4%
Largest China position, held 4.5 years; still undervalued vs $137 intrinsic value pre-earnings. Will scale out once price reaches 20-30% above revised intrinsic value.
CSU	Feb 06, 2026	$2,194.86	—	—
Acquirer of 800 vertical market software businesses with deep niche System of Record moats; diversified across verticals acts as a hedge
GOOGL	Jan 27, 2026	$334.55	$326.56	-2.4%
ChatGPT fears and antitrust narratives were emotional; revenue, operating income, and free cash flow kept growing.
META	Jan 27, 2026	$672.97	$593.87	-11.8%
Ad cycle drop, Apple privacy changes, and metaverse spending were temporary; confirmed duopoly power by verifying own company's ad spend.
MSFT	Feb 06, 2026	$401.14	$389.10	-3.0%
Provides all 3 enterprise tech layers, owns Azure AI infrastructure, highly resilient to AI disruption
NOW	Jan 13, 2026	$138.19	$105.56	-23.6%
Undervalued, down 20% in 2025. Dropped for a stupid reason (the $7B Armis acquisition). Prime beneficiary of agentic AI.
PLTR	Jan 27, 2026	$165.70	$131.53	-20.6%
Share price drop was emotional while business fundamentals remained strong.
SPY	Jul 01, 2026	$745.76	$739.09	-0.9%
Stay invested through the ups and downs; wealth will grow over time.
VEEV	Feb 06, 2026	$183.65	$194.46	+5.9%
Specialized CRM for health sciences, deep regulatory data model, enormous switching costs due to validation requirements
AIQ	Jan 16, 2026	$52.34	$58.30	+11.4%
Best-performing robotics/AI ETF in his research; DCA strategy: buy at 20-week EMA for initial adds, 50-week MA for deeper corrections, previous swing low as third support; buy in tranches never all at once.
ASML	Jan 13, 2026	$1,270.16	$1,655.26	+30.3%
Core portfolio holding; done really well last year. Currently overvalued at $1280 vs $871 intrinsic—will add on wave down, never chase after wave up.
AVGO	Jan 13, 2026	$354.61	$383.22	+8.1%
Slightly undervalued at $352 vs $405 intrinsic. Earnings and cash flow have outpaced share price growth. Projected 20.88% growth next 5 years.
CRM	Jan 13, 2026	$241.06	$173.60	-28.0%
Undervalued, down 20% in 2025. Prime beneficiary of agentic AI; consumption-based pricing model solves license-reduction risk from AI.
CRWD	Feb 25, 2026	$90.83	$180.11	+98.3%
Selling cash-secured puts to target share assignment at a lower price; owns shares but waiting for a bigger discount to buy directly; target $332.
LLY	Jan 16, 2026	$1,038.40	$1,197.53	+15.3%
Now fairly/slightly undervalued after generating huge profits; analysts project 30% growth over 5 years, 18% long-term; worth ~$113 intrinsic value; stronger than NVO with leadership in obesity, oncology, and Alzheimer's; would buy LLY first if he owned neither.
NVO	Jan 16, 2026	$62.33	$49.67	-20.3%
Still very undervalued ~35-36% below intrinsic value at ~$57; new management regaining market share; priced for only 4% long-term growth which is overly pessimistic; share price could double if they return to double-digit growth.
WM	Jan 13, 2026	$216.18	$237.90	+10.1%
Bought a pretty big position. Uses AI to become more efficient and grow profit margins.
DBS	Jan 13, 2026	$28.68	$28.68	+0.0%
Owns; currently overvalued and overextended short-term. Uses a lot of AI to increase margins, but will wait for a wave down before adding more.
HCA	Jan 16, 2026	$469.29	$389.62	-17.0%
Biggest private hospital chain in the US; fundamentally great company; part of larger preference for hospital and medical device stakes over drug companies.
ISRG	Jan 16, 2026	$535.00	$356.83	-33.3%
Very high quality, strong moat, high predictability and profitability, but currently overvalued: intrinsic value ~$247, trading ~$541; P/E ~75x, forward P/E ~55x; priced to perfection with no margin of safety.
SHLD	Jan 16, 2026	$77.91	$63.85	-18.1%
One of his best performers, up ~75%; owns high-tech defense companies including unmanned drones and military robotics; still invested.
AAPL	Jan 27, 2026	$258.27	$336.91	+30.4%
Fundamentals remained intact despite temporary price drop.
ACGL	Jul 09, 2026	$101.70	$103.88	+2.1%
Specialty insurance company making a lot of money with almost no AI exposure; part of the 60% non-AI portion of his portfolio.
AIPO	Jan 05, 2026	$23.32	$29.03	+24.5%
To diversify risk across the AI power ecosystem rather than overvalued individual companies without moats.
BKNG	Feb 25, 2025	$201.35	$186.79	-7.2%
Within his circle of competence
EWH	Feb 20, 2025	$16.99	$22.78	+34.1%
Still holding as a China position.
FTNT	May 23, 2026	$133.93	$152.38	+13.8%
Cybersecurity stocks left for dead but surged back recently as market realized they are necessary.
JD	Feb 20, 2025	$41.19	$30.95	-24.9%
Still holding as part of expected 1-3 year China bull-market window.
KWEB	Feb 20, 2025	$35.59	$27.00	-24.1%
Still holding through 1-3 year China bull-market thesis.
LOW	Feb 01, 2025	$260.04	$211.55	-18.6%
May be short-term impacted by tariffs but long-term thesis intact.
MA	May 23, 2026	$498.54	$551.71	+10.7%
Growing stronger than Visa; projected 15% growth for next 3-5 years.
MELI	Feb 25, 2025	$2,168.60	$1,819.74	-16.1%
Within his circle of competence
MSCI	Mar 28, 2026	$523.40	$571.03	+9.1%
Grabbed some shares but considers it overvalued again.
NKE	Feb 01, 2025	$76.90	$42.14	-45.2%
Owns a small position; footwear reliant on Chinese manufacturing creating short-term headwind for turnaround.
NUKZ	Jan 05, 2026	$68.02	$64.35	-5.4%
Selling cash-secured put options to gain exposure to nuclear and uranium-focused ETFs while generating premium.
PANW	Jan 27, 2026	$183.50	$317.32	+72.9%
Cybersecurity is a long-term megatrend with short-term IT spending cycles.
PNGAY	Feb 20, 2025	$11.93	$14.54	+21.9%
Still holding as a China position.
SPGI	May 23, 2026	$395.08	$439.83	+11.3%
Underlying fundamentals growing significantly; benefits from royalties on S&P/Dow Jones brands.

Recent calls

hold